Hormonal
Liraglutide, a GLP-1 receptor agonist, improves glycemic control and reduces body weight in type 2 diabetes through glucose-dependent insulin secretion, glucagon suppression, and delayed gastric emptying, with a low risk of hypoglycemia.
Liraglutide is a once-daily injection for type 2 diabetes that helps control blood sugar and promotes weight loss. It works by mimicking a natural hormone (GLP-1) to increase insulin when blood sugar is high and decrease glucagon. Because it only works when blood sugar is elevated, it has a low risk of causing dangerously low blood sugar. Treatment starts at a lower dose to minimize stomach issues, then increases based on how well it controls your blood sugar.
The beneficial pharmacodynamic actions of liraglutide, including improved fasting and postprandial glycaemic control (mediated by increased insulin and reduced glucagon levels and minor delays in gastric emptying), reduced appetite and energy intake, and effects on postprandial lipid profiles.
Why this rating
Based on a comprehensive review of multiple phase III trials and pharmacokinetic/pharmacodynamic studies.
Source
Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics
Lisbeth V. Jacobsen et al. · Clinical Pharmacokinetics · 2015
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →